Golden logo
    Create a WorkspaceQuery ToolSaved QueriesDatasetsData RequestsListsPipelinesFollowed Topics
    Invite MembersWorkspace SettingsUpgrade WorkspaceAPI AccessPricingHelp & SupportMore
Log in
Enquire now

List of recordati patents

List of recordati patents
List of Pinnpack Packaging Llc patents
List of Zoomdata patents
List of OG Technologies, Inc. patents
List of companies in Israel Growth Partners's investment portfolio
List of companies in Nassau Street Ventures's investment portfolio
Patents where
Current Assignee
Name
is
recordatirecordati
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7173153 Sertraline hydrochloride form II and methods for the preparation thereof

Patent 7173153 was granted and assigned to recordati on February, 2007 by the United States Patent and Trademark Office.

recordati
recordati
United States Patent and Trademark Office
United States Patent and Trademark Office
7173153
February 6, 2007
‌
US Patent 11602509 Salt of cysteamine for the preparation of highly respirable particles

recordati
recordati
recordati
recordati
United States Patent and Trademark Office
United States Patent and Trademark Office
11602509
March 14, 2023
‌
US Patent 11440922 Heterocyclylmethylidene derivatives and their use as modulators of mGluR5 receptors

recordati
recordati
recordati
recordati
United States Patent and Trademark Office
United States Patent and Trademark Office
11440922
September 13, 2022
‌
US Patent 8703955 Process for the resolution of isoquinoline derivatives

Patent 8703955 was granted and assigned to recordati on April, 2014 by the United States Patent and Trademark Office.

recordati
recordati
United States Patent and Trademark Office
United States Patent and Trademark Office
8703955
April 22, 2014
‌
US Patent 11135173 Prolonged release pharmaceutical composition comprising cysteamine or salt thereof

Patent 11135173 was granted and assigned to recordati on October, 2021 by the United States Patent and Trademark Office.

recordati
recordati
recordati
recordati
United States Patent and Trademark Office
United States Patent and Trademark Office
11135173
October 5, 2021
‌
US Patent 11591337 Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of mGlu5 receptors

recordati
recordati
recordati
recordati
United States Patent and Trademark Office
United States Patent and Trademark Office
11591337
February 28, 2023
‌
US Patent 7683179 Lercanidipine salts

Patent 7683179 was granted and assigned to recordati on March, 2010 by the United States Patent and Trademark Office.

recordati
recordati
United States Patent and Trademark Office
United States Patent and Trademark Office
7683179
March 23, 2010
‌
US Patent 7189876 Methods for preparing sertraline hydrochloride polymorphs

Patent 7189876 was granted and assigned to recordati on March, 2007 by the United States Patent and Trademark Office.

recordati
recordati
United States Patent and Trademark Office
United States Patent and Trademark Office
7189876
March 13, 2007
‌
US Patent 8580962 Spiroheterocyclic compounds as mGlu5 antagonists

recordati
recordati
United States Patent and Trademark Office
United States Patent and Trademark Office
8580962
November 12, 2013
9 results
0 selected
9 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
  • Save query
  • Access by API
  • Ascending
  • Descending
  • Ascending
  • Descending
  • Ascending
  • Descending
  • Ascending
  • Descending
  • Ascending (count)
  • Descending (count)
  • Ascending
  • Descending
  • Ascending
  • Descending
  • Ascending
  • Descending
    • Home
    • Product
    • Data CreditsNEW
    • DatasetsNEW
    • ChatGPT Plugin
    • API
    • CRM Integration
    • Careers
    • Blog

    • Terms of Service
    • API Documentation

  • Contact Us